Recent Analyst Forecasts and Stock Ratings
ProQR Therapeutics N.V. FAQ's
ProQR Therapeutics N.V. has been rated by research analysts at Loop Capital Markets, Raymond James, Cantor Fitzgerald, Chardan Capital in the past 90 days.
ProQR Therapeutics N.V. has been rated by research analysts at Loop Capital Markets, Raymond James, Cantor Fitzgerald, Chardan Capital in the past 90 days.